This study describes estrogen use among 45- to 55-year-old white women in Massachusetts from 1981 to 1987. In a 1981 cross-sectional survey, 7705 white women (77 percent response rate) returned a questionnaire or were interviewed by phone. Premenopausal women were invited into a 4.5-year follow-up study including telephone interviews every nine months, and 2236 (approximately 91 percent of the eligible women) had a complete follow-up. In the cross-sectional survey, 7.9 percent had used oral estrogens in the last two weeks, but most (77 percent) had had a hysterectomy; use varied notably from one area to another. Vaginal estrogens were used by 2.9 percent. Users and nonusers of oral estrogens were quite similar in regard to sociodemographic background. Data from the follow-up surveys showed that estrogen use increased throughout the study period and by the final follow-up women with higher education status reported more estrogen use than those with lower education status. Most women used estrogens only for a short time.
Get full access to this article
View all access options for this article.
References
1.
BushTLBarrett-ConnorE. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev1985; 7: 80–104.
2.
KennedyDLBaumCForbesMB. Noncontraceptive estrogens and progestins: Use patterns over time. Obstet Gynecol1985; 65: 441–6.
3.
HemminkiEKennedyDLBaumCMcKinlaySM. Prescribing of noncontraceptive estrogens and progestins in the United States 1974–1986. Am J Public Health1988; 78: 1479–81.
4.
PasleyBHStandfastSJKatzSH. Prescribing estrogen during menopause: Physician survey of practices in 1974 and 1981. Public Health Rep1984; 99: 424–9.
5.
HolzmanGBRavtichMMMethenyWRothertMLHolmesMHoppeRB. Physicians' judgements about estrogen replacement therapy for menopausal women. Obstet Gynecol1984; 63: 303–11.
6.
Barrett-ConnorE. Postmenopausal estrogens—current prescribing patterns of San Diego gynecologists. West J Med1986; 144: 620–1.
7.
RossRKPaganini-HillARoySChaoAHendersonBE. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: Possible implications for public health. Am J Public Health1988; 78: 516–9.
8.
Barrett-ConnorE. Postmenopausal estrogen, cancer and other considerations. Women Health1986; 11: 179–95.
9.
BeagleholeR. Estrogens and cardiovascular disease. Br Med J1988; 297: 571–2.
10.
BuringJEBainCJEhrmanRL. Conjugated estrogen use and risk of endometrial cancer. Am J Epidemiol1986; 124: 434–41.
11.
CriquiMHSurrezLBarrett-ConnorEMcPhilipsJWingardDLGarlandC. Postmenopausal estrogen use and mortality. Am J Epidemiol1988; 128: 606–14.
12.
ErnsterKLBushTLHugginsGRHulkaBSKelseyJLScottenfeldD. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med1988; 17: 201–23.
13.
Paganini-HillARossRKHendersonBE. Postmenopausal oestrogen treatment and stroke: A prospective study. Br Med J1988; 297: 519–22.
14.
PerssonI. The risk of endometrial and breast cancer after estrogen treatment. Acta Obstet Gynecol Scand1985; 130 (suppl):59–66.
15.
PetittiDBPerlmanJASidneyS. Noncontraceptive estrogens and mortality: Long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol1987; 70: 289–93.
16.
RosenbergLArmstrongBJickH. Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med1976; 294: 1256–9.
17.
WingoPALaydePMLeeNCRubinGOryHW. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA1987; 257: 209–15.
18.
HemminkiE. Use of combined estrogen-progestin replacement therapy—an example of the dissemination of new indications for an old technology. Int J Technol Assess Health Care1988; 4: 511–9.
19.
McKinlaySMBifanoNLMcKinlayJ. Smoking and age at menopause in womenAnn Intern Med1985; 103: 350–6.
20.
McKinlayJBMcKinlaySMBrambillaDJ. Health status and utilization behavior associated with menopause. Am J Epidemiol1987; 125: 110–21.
21.
Svensk Läkemedelsstatistik 1987. Stockholm: Apoteksbolaget, 1987: 69.
22.
StadelBVWeissN. Characteristics of menopausal women: A survey of King and Pierce counties in Washington, 1973–1974. Am J Epidemiol1975; 102: 209–16.
23.
PfefferRI. Estrogen use in postmenopausal women. Am J Epidemiol1977; 105: 21–9.
24.
WilsonPNFGarrisonRJCastelliWP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med1985; 313: 1038–43.
25.
GreenwaldPCaputoTAWolfgangPE. Endometrial cancer after menopausal use of estrogens. Obstet Gynecol1977; 50: 239–43.
26.
StandevenMCriquiMHKlauberMRGabrielSBarrett-ConnorE. Correlates of change in post-menopausal estrogen use in a population-based study. Am J Epidemiol1986; 124: 268–74.
27.
StampferMIWillettWCColditzGARosnerBSpeizerFEHennekensCH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med1985; 313: 1044–9.
28.
RosenbergLShapiroSKaufmanDWSloneDMiettinenOSStolleyPD. Patterns and determinants of conjugated estrogen use. Am J Epidemiol1979; 109: 676–86.
29.
WeissNSSzekelyDREnglishDRSchweidAI. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA1979; 242: 261–4.
30.
BuringJEBainCJEhrmannRL. Conjugated estrogen use and risk of endometrial cancer. Am J Epidemiol1986; 124: 434–41.
31.
BushTCowenLBarrett-ConnorECriquiM. Estrogen use and all cause mortality. JAMA1983; 249: 903–6.
32.
EgelandGMMatthewsKAKullerLHKelseySF. Characteristics of noncontraceptive hormone users. Prev Med1988; 17: 403–11.
33.
McKinlaySMMcKinlayJ. Health status and health care utilization by menopausal women. In: MastroianniLPaulsenCA, eds. Aging, reproduction, and the climacteric. New York: Plenum Publishing, 1986: 243–62.
